Mahjoubin-Tehran, M., Kovanen, P. T., Xu, S., Jamialahmadi, T., & Sahebkar, A. (2020). Cyclodextrins: Potential therapeutics against atherosclerosis. Pharmacology & Therapeutics, 107620. PMID32599008doi:10.1016/j.pharmthera.2020.107620
Anderson A.M., Manet I., Malanga M., Clemens D.M., Sadrerafi K., Piñeiro Á., García-Fandiño R., O’Connor M.S., 2024. Addressing the complexities in measuring cyclodextrin-sterol binding constants: A multi-dimensional study. Carbohydrate Polymers 323, 121360. doi:10.1016/j.carbpol.2023.121360
Benitez Amaro, A., Solanelles Curco, A., Garcia, E., Julve, J., Rives, J., Benitez, S., & Llorente Cortes, V. (2021). Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis. Journal of Clinical Medicine, 10(16), 3571. PMID34441867PMC8396846doi:10.3390/jcm10163571
Garber, D. W., Goldberg, D., & Anantharamaiah, G. M. (2015). Apolipoprotein E Mimetic Peptides: Cholesterol-Dependent and Cholesterol-Independent Properties. In Apolipoprotein Mimetics in the Management of Human Disease (pp. 135—156). Springer International Publishing. doi: 10.1007/978-3-319-17350-4_10
Anantharamaiah, G. M., & Goldberg, D. (2015). Novel method for reducing plasma cholesterol: a ligand replacement therapy. Clinical lipidology, 10(1), 83-90. , doi:10.2217/clp.14.63
Graham, M.J., N. Viney, R. Crooke, and S. Tsimikas. (2016). Antisense Inhibition of Apolipoprotein(a) to Lower Plasma Lipoprotein(a) Levels in Humans. J Lipid Res doi:10.1194/jlr.R052258
Dossena, M., Ferrario, A., Lopardo, V., Ciaglia, E., & Puca, A. A. (2020). New Insights for BPIFB4 in Cardiovascular Therapy. International Journal of Molecular Sciences, 21(19), 7163. PMID32998388PMC7583974doi:10.3390/ijms21197163
Vasdev S., Gill V., Singal P.K. Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms (англ.) // Vascular Health and Risk Management[англ.] : journal. — 2006. — Vol. 2, no. 3. — P. 263—276. — PMID17326332. — PMC1993980.
Mahjoubin-Tehran, M., Kovanen, P. T., Xu, S., Jamialahmadi, T., & Sahebkar, A. (2020). Cyclodextrins: Potential therapeutics against atherosclerosis. Pharmacology & Therapeutics, 107620. PMID32599008doi:10.1016/j.pharmthera.2020.107620
Bhargava, P., Dinh, D., Teramayi, F., Silberg, A., Petler, N., Anderson, A. M., ... & O’Connor, M. S. (2023). Selective Removal of 7KC by a Novel Atherosclerosis Therapeutic Candidate Reverts Foam Cells to a Macrophage-like Phenotype. bioRxiv. PMID37961383PMC10634755 {{DOI: 10.1101/2023.10.23.563623}}
Benitez Amaro, A., Solanelles Curco, A., Garcia, E., Julve, J., Rives, J., Benitez, S., & Llorente Cortes, V. (2021). Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis. Journal of Clinical Medicine, 10(16), 3571. PMID34441867PMC8396846doi:10.3390/jcm10163571
Dossena, M., Ferrario, A., Lopardo, V., Ciaglia, E., & Puca, A. A. (2020). New Insights for BPIFB4 in Cardiovascular Therapy. International Journal of Molecular Sciences, 21(19), 7163. PMID32998388PMC7583974doi:10.3390/ijms21197163
